IGC-1C Targets Tau Protein and GLP-1 Receptor, Offering a Multi-Pathway Approach to Neurodegenerative and Metabolic Disease Treatment POTOMAC, Md., August 22, 2024--(BUSINESS WIRE)--IGC Pharma, Inc.

Kaizer Chiefs fans have renewed hope of signing Percy Tau after recent events in Egypt. Kaizer Chiefs have prioritized the ...

Kaizer Chiefs-linked Percy Tau continues to be mentioned along side an Al Ahly exit ahead of next season. Tau still has more ...

Voyager Therapeutics, Inc. (NASDAQ:VYGR) is in the process of developing its anti-Tau antibody VY7523 for the treatment of patients with Alzheimer's Disease [AD] in a phase 1a single-ascending ...

Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for ...

A new study has somewhat redeemed the tau protein, which up to now has been associated with the development of Alzheimer’s disease. Turns out, the protein has a ‘good guy’ role, helping to ...